Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer
Backgrounds The present study was designed to identify the preoperative parameters, including PSA‐based parameters, and endorectal MRI, predictive of pathological stage in males who underwent radical prostatectomy. Methods We studied 114 patients who underwent radical retropubic prostatectomy and pe...
Gespeichert in:
Veröffentlicht in: | The Prostate 2003-06, Vol.56 (1), p.23-29 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Backgrounds
The present study was designed to identify the preoperative parameters, including PSA‐based parameters, and endorectal MRI, predictive of pathological stage in males who underwent radical prostatectomy.
Methods
We studied 114 patients who underwent radical retropubic prostatectomy and pelvic lymphadenectomy for clinically localized prostate cancer. Clinical stage was assessed by DRE, pelvic CT scan, endorectal MRI, and bone scan. The correlation between the preoperative parameters, including PSA‐based parameters, clinical stage, and histological findings of biopsy specimens, and the pathological stage was analyzed. Logistic regression analysis was performed to identify a significant set of independent predictors for local extent of disease.
Results
Seventy‐six (66.6%) patients had organ confined cancer and 38 (33.4%) patients had extraprostatic cancer. Of the 38 patients with extraprostatic cancer, four had seminal vesicle involvement, while, none had pelvic lymph node involvement. Biopsy Gleason score, PSA, PSA‐α1‐antichymotrypsin (PSA‐ACT), PSA‐density (PSAD), PSA‐transition zone density, PSA‐ACT density, and PSA‐ACT transition zone (TZ) density were significantly higher and percent free PSA was lower in the patients with organ confined cancer than those with extraprostatic cancer (P |
---|---|
ISSN: | 0270-4137 1097-0045 |
DOI: | 10.1002/pros.10239 |